The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary awardee and has issued a $450,000 sub-award to the University of Pennsylvania to collaborate on this research. The Military Medical Research and Development program supports a broad range of biomedical research initiatives to improve health outcomes for military service members, veterans, and the general public.
Generated 1/28/25, 9:12 AM